Nesiritide is reduces filling pressures rapidly and effectively in patients with decompensated congestive heart failure (CHF) and concomitant renal insufficiency, researchers announced here on November 19th at the 2002 Scientific Sessions of the American Heart Association (AHA).
The drug also appeared to be well tolerated by these patients, according to Dr. Javed Butler, with the Cleveland Clinic Foundation in Cleveland, Ohio, United States.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!